Saw it on Bloomberg. Pfizer, under pressure to improve bottom line Pfizer has set aside, I think it was $US19 Billion to aquire new possible blockbuster drugs.
Solbecs new CEO was in charge of new drug developement in the US for Pfizer, if I remember correctly.